ClinicalTrials.gg
RecruitingNCT07444151ReFastUpdated Mar 2, 2026

Post-Stroke Fatigue Perception Study (ReFast)

An observational study in Post-stroke Fatigue, sponsored by School of Health Sciences Geneva. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by School of Health Sciences Geneva · Observational

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 216 studies in Stroke with a site in Switzerland — 46 open to participants now, 60 under way, 6 of them phase 3. Stroke · Switzerland.

Planned enrollment
61st of 69
30 · median 200
Started
2026
with 11 others
Observational
69 of 216
16 open now
Primary completion
2026-12
later than 22 of 59 live
Registered
203rd of 216
by date

Among the 216 studies in Stroke with a site in Switzerland, this one is the 61st largest by planned enrollment of the 69 observational ones that give a count, is one of 12 that started in 2026, is one of 69 observational ones, reaches primary completion later than 22 of the 59 other live ones, and was the 203rd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

46 of the 216 studies in Stroke with a site in Switzerland are open now. Recruiting first, the newest first:

40 more — sign in →

All 46 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 216 studies in Stroke with a site in Switzerland, or all of them as a file.
02

Study summary

The goal of this observational study is to better understand fatigue after stroke. Many people feel ongoing tiredness months or years after a stroke. This fatigue may affect daily activities, work, and social life. It does not always improve with rest.

This study aims to answer these questions:

How do participants describe their fatigue?

How strong and how often does it occur?

How does it affect daily life and quality of life?

What strategies do participants use to manage it?

About 20 to 30 adults living in French-speaking Switzerland who have had a stroke will take part.

Participants will:

Complete one anonymous questionnaire online or on paper.

Answer questions about their fatigue and daily life.

Share their experience in their own words.

The questionnaire takes about 15 to 20 minutes. There are no medical tests, treatments, or follow-up visits.

Participation is voluntary. Participants may stop at any time. No names or identifying information are collected.

The results may help health professionals better understand post-stroke fatigue and improve rehabilitation care.

Read the detailed description

Post-stroke fatigue is a common and long-lasting symptom experienced by many people after a stroke. It is described as persistent physical, cognitive, or emotional exhaustion that is not proportional to effort and does not consistently improve with rest. Although fatigue can strongly affect participation, autonomy, and quality of life, it remains insufficiently understood and often under-recognized in rehabilitation practice.

The ReFast study (Recovery and Fatigue Study) is a non-interventional, cross-sectional observational study conducted in French-speaking Switzerland. The aim is to explore the subjective experience of post-stroke fatigue in adults living at home in the chronic phase after stroke. The study focuses on understanding how participants perceive their fatigue, how it affects daily life, and which coping strategies they use.

Data will be collected through a single anonymous questionnaire that combines structured questions (including rating scales and multiple-choice items) with open-ended questions. This mixed-methods approach allows both quantitative description and qualitative exploration of participants' experiences.

Primary outcomes relate to the presence, intensity, frequency, and functional impact of fatigue. Secondary outcomes include perceived quality of life, coping strategies, perceived social or professional support, and contextual factors such as age and time since stroke. Open-ended responses will be analyzed using inductive thematic analysis to identify recurring themes and patterns.

The study does not involve any medical intervention, clinical examination, or follow-up visit. Participation consists of completing one questionnaire session. All data are collected anonymously, and no identifying information is recorded. The overall risk is minimal and limited to possible mild emotional discomfort when reflecting on personal experiences.

By integrating quantitative and qualitative perspectives, this study seeks to generate clinically relevant insights into post-stroke fatigue. The findings may support the development of more patient-centered rehabilitation approaches and inform future research in neurological rehabilitation.

03

Conditions studied

  • Post-stroke Fatigue

Browse trials for

Keywords

  • Post-Stroke Fatigue
  • Quality of Life
  • Coping Strategies
  • Questionnaire Study
  • Neurological Rehabilitation
  • Stroke
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adults aged 18 years or older living in French-speaking Switzerland who have experienced an ischemic or hemorrhagic stroke and report persistent fatigue in the chronic phase. Participants live in the community and are able to read and understand written French. The study focuses on individuals who self-identify fatigue as a consequence of stroke and who are able to independently complete an anonymous questionnaire about their experience.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Living in French-speaking Switzerland
  • Confirmed history of ischemic or hemorrhagic stroke
  • Self-reported fatigue attributed to stroke
  • Living in the community (not institutionalized)
  • Able to read and understand written French
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • (TIA) without confirmed stroke
  • History of two or more strokes
  • Currently institutionalized (e.g., nursing home, long-term hospital care, rehabilitation center)
  • Fatigue primarily caused by another chronic medical condition (e.g., cancer, primary depression, multiple sclerosis)
  • Severe cognitive or communication impairment preventing independent completion of the questionnaire
  • Unable to understand written French
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adults With Chronic Stroke and Post-Stroke Fatigue

    Adults aged 18 years or older living in French-speaking Switzerland who have experienced a stroke and report persistent fatigue in the chronic phase (six months or more after stroke). Participants live in the community and complete one anonymous questionnaire about their experience of fatigue, its impact on daily life, and coping strategies. No medical intervention or follow-up is involved.

06

What researchers measure

Primary outcomes

  1. Fatigue Severity Scale (FSS) Total Score

    Fatigue severity will be assessed using the Fatigue Severity Scale (FSS), a validated 9-item questionnaire measuring subjective fatigue and its functional impact. Each item is rated on a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). The total score is calculated as the mean of the 9 items and ranges from 1 to 7. Higher scores indicate greater fatigue severity.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  2. Presence of Self-Reported Post-Stroke Fatigue

    Presence of post-stroke fatigue will be assessed using a study-specific Post-Stroke Fatigue Questionnaire developed for this cross-sectional study. Participants respond "Yes" or "No" to a binary item assessing whether they have experienced unusual fatigue since their stroke. This is a categorical variable (Yes/No). The proportion of participants reporting "Yes" will be calculated. Higher frequency of "Yes" responses indicates greater prevalence of self-reported post-stroke fatigue.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  3. Self-Reported Fatigue Intensity

    Fatigue intensity will be assessed using the study-specific Post-Stroke Fatigue Questionnaire. The Fatigue Intensity Score is calculated as the mean of multiple items rated on a 5-point Likert scale ranging from 1 (low fatigue) to 5 (very high fatigue). The score ranges from 1 to 5. Higher scores indicate greater perceived fatigue intensity.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  4. Self-Reported Functional Impact of Fatigue on Daily Activities

    Functional impact of fatigue on daily activities (e.g., household tasks, work, leisure, rehabilitation) will be assessed using multiple structured items from the study-specific questionnaire. Each item is rated on a 5-point Likert scale ranging from 1 (no impact) to 5 (very high impact). The Functional Impact Score is calculated as the mean of these items and ranges from 1 to 5. Higher scores indicate greater functional limitation related to fatigue.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  5. Self-Reported Frequency of Post-Stroke Fatigue

    Frequency of fatigue will be assessed using a structured categorical item in the study-specific questionnaire with predefined response options (e.g., daily, several times per week, occasionally, rarely). This is an ordinal categorical variable. Higher frequency categories reflect more frequent fatigue episodes.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  6. Self-Reported Quality of Life Related to Fatigue

    Quality of life related to fatigue will be assessed using multiple Likert-scale items from the study-specific questionnaire. Each item is rated from 1 (very poor quality of life) to 5 (very good quality of life). The Quality of Life Score is calculated as the mean of these items, ranging from 1 to 5. Higher scores indicate better perceived quality of life.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  7. Self-Reported Coping Strategies for Managing Fatigue

    Coping strategies used to manage fatigue (e.g., rest breaks, activity planning, physical activity) will be assessed using predefined multiple-choice items and optional open-ended responses in the study-specific questionnaire. Results will be summarized descriptively as counts and percentages.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  8. Perceived Social and Professional Support

    Perceived social and professional support will be assessed using multiple Likert-scale items from the study-specific questionnaire. Each item is rated on a 5-point Likert scale ranging from 1 (no perceived support) to 5 (very strong perceived support). The Support Score is calculated as the mean of these items, ranging from 1 to 5. Higher scores indicate greater perceived support.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

Secondary outcomes

  1. Qualitative Description of Subjective Fatigue Experience

    Open-ended responses describing the subjective experience of fatigue, including emotional, cognitive, and functional aspects, will be collected. Responses will undergo inductive thematic analysis.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

  2. Sociodemographic and Clinical Contextual Variables

    Sociodemographic and clinical characteristics including age, sex, time since stroke, employment status, level of autonomy, and comorbidities will be collected for descriptive and stratification purposes. These are descriptive variables.

    Time frame: Assessed once at enrollment (single study visit, Day 0)

07

Study locations

1 of 1 sites recruiting
  • Haute école de santé de Genève (HEdS - HES-SO)
    Carouge, Canton of Geneva 1227, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because all data are collected anonymously and without any direct or indirect identifiers. The dataset is limited to a small exploratory sample collected within the framework of an academic Bachelor project. In accordance with the study protocol and institutional policies, the data are intended solely for the objectives described in the approved research project. Any future reuse of the data would require a new ethics application and approval.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 16, 2026
First posted
Mar 2, 2026
StartActual
Jan 27, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07444151
Lead sponsor
School of Health Sciences Geneva
Responsible party
Pierre Nicolo, PhD (Professor, School of Health Sciences Geneva) — Principal investigator
First posted
Mar 2, 2026
Start date
Jan 27, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 2, 2026

Study contacts

Pierre Nicolo, PhD
Contact
pierre.nicolo@hesge.ch
+41079263543 ext. +41 22 558 64
Pierre Nicolo, PhD
principal investigator · HEdS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion